Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age
Titel:
Safety and immunogenicity of a hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 3, 4, and 12–14 months of age
Auteur:
Halperin, Scott A. Tapiero, Bruce Diaz-Mitoma, Francisco Law, Barbara J. Hoffenbach, Agnes Zappacosta, Pamela S. Radley, David McCarson, Barbara J. Martin, Jason C. Brackett, Laura E. Boslego, John W. Hesley, Teresa M. Bhuyan, Prakash K. Silber, Jeffrey L.